DNA mismatch repair-dependent response to fluoropyrimidine-generated damage. (Q40478691)

20 September 2017

title

DNA mismatch repair-dependent response to fluoropyrimidine-generated damage. (English)

1 reference

20 September 2017

1 reference

Mark Meyers

1 reference

20 September 2017

Mark W Wagner

1 reference

20 September 2017

Anthony Mazurek

1 reference

20 September 2017

Christoph Schmutte

1 reference

20 September 2017

Richard Fishel

1 reference

20 September 2017

David A Boothman

1 reference

20 September 2017

language of work or name

English

0 references

publication date

14 December 2004

1 reference

Journal of Biological Chemistry

20 September 2017

published in

1 reference

20 September 2017

volume

280

1 reference

20 September 2017

1 reference

20 September 2017

page(s)

5516-5526

1 reference

Mismatch repair in replication fidelity, genetic recombination, and cancer biology

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Mismatch repair, molecular switches, and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Mammalian DNA mismatch repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Mechanisms of tolerance to DNA damaging therapeutic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Mismatch binding proteins and tolerance to alkylating agents in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Mismatch repair proficiency and in vitro response to 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Resistance to 6-thioguanine in mismatch repair-deficient human cancer cell lines correlates with an increase in induced mutations at the HPRT locus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

DNA mismatch repair and mutation avoidance pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

DNA mismatch repair and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Molecular genetics and clinical-pathology features of hereditary nonpolyposis colorectal carcinoma (Lynch syndrome): historical journey from pedigree anecdote to molecular genetic confirmation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Microsatellite instability in squamous cell carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

A role for DNA mismatch repair in sensing and responding to fluoropyrimidine damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

The effect of O6-methylguanine DNA adducts on the adenosine nucleotide switch functions of hMSH2-hMSH6 and hMSH2-hMSH3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Activation of human MutS homologs by 8-oxo-guanine DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Biphasic kinetics of the human DNA repair protein MED1 (MBD4), a mismatch-specific DNA N-glycosylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Base excision repair of DNA in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Resistance to tomudex (ZD1694): multifactorial in human breast and colon carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Involvement of bcl-2 and p21waf1 proteins in response of human breast cancer cell clones to Tomudex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

The role of mismatched nucleotides in activating the hMSH2-hMSH6 molecular switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Functional interactions and signaling properties of mammalian DNA mismatch repair proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Somatic frameshift mutations in the MBD4 gene of sporadic colon cancers with mismatch repair deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

5-Fluorouracil: mechanisms of action and clinical strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Biochemical pharmacology and analysis of fluoropyrimidines alone and in combination with modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Substrate recognition by a family of uracil-DNA glycosylases: UNG, MUG, and TDG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Functional interaction of proliferating cell nuclear antigen with MSH2-MSH6 and MSH2-MSH3 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Proliferating cell nuclear antigen and Msh2p-Msh6p interact to form an active mispair recognition complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

hMSH3 and hMSH6 interact with PCNA and colocalize with it to replication foci

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

The Bloom's syndrome protein (BLM) interacts with MLH1 but is not required for DNA mismatch repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

The interaction of DNA mismatch repair proteins with human exonuclease I

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Physical interaction between components of DNA mismatch repair and nucleotide excision repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Radiotherapy in conjunction with intravenous infusion of 180 mg of disodium pamidronate in management of osteolytic metastases from breast cancer: clinical evaluation, biochemical markers, quality of life, and monitoring of recalcification using ass

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Dominant effects of an Msh6 missense mutation on DNA repair and cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Tumour markers of prognosis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Molecular predictors of survival after adjuvant chemotherapy for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

Mismatch correction at O 6 -methylguanine residues in E. coli DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M412105200

21 January 2018

Identifiers

DOI

10.1074/JBC.M412105200

1 reference

20 September 2017

1 reference